Status:
COMPLETED
Frontoparietal Priority Maps as Biomarkers for MTBI
Lead Sponsor:
University of Minnesota
Conditions:
TBI (Traumatic Brain Injury)
Ocular Motility Disorders
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine whether there is a quantitative relationship between brain processes seen by a MRI and visual deficits caused by mild to moderate traumatic brain injuries (mT...
Detailed Description
Participants with mTBI, as well as healthy control participants, will be invited to participate in up to two study visits. Both visits will occur at the University of Minnesota's Center for Magnetic R...
Eligibility Criteria
Inclusion
- Normal or corrected to normal visual acuity
- No previously documented mTBI (target: 16 out of 88 participants invited for Visit 1)
- Previously documented mTBI (target: 72 out of 88 participants invited for Visit 1)
- Vision impairment (target: 48 out of 88 participants invited for Visit 1; expected to be comorbid with mTBI, but non-TBI participants with oculomotor impairments will not be excluded)
Exclusion
- Current use of neuroactive drugs or medications
- Presence of neurological disorders (other than mTBI and mild PTSD)
- Contraindications for MRI (metal in the body, claustrophobia, diabetes or other diseases or drugs that affect thermoregulation)
- Inability to comply with behavioral task instructions
Key Trial Info
Start Date :
July 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2018
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT02251002
Start Date
July 1 2015
End Date
October 1 2018
Last Update
March 21 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.